Variations in ATP7A with a small effect on protein function might reduce the rate of copper accumulation in humans with Wilson disease, thereby modifying the disease phenotype, for example by delaying the age at onset of clinical symptoms. The gene discussed is ATP7A; the disease is Wilson disease.